awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35124844-2312F6C2-3456-4ADC-A26C-4BD2C5FAF368
Q35124844-2312F6C2-3456-4ADC-A26C-4BD2C5FAF368
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35124844-2312F6C2-3456-4ADC-A26C-4BD2C5FAF368
Choosing first-line therapy for chronic lymphocytic leukemia.
P2860
Q35124844-2312F6C2-3456-4ADC-A26C-4BD2C5FAF368
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35124844-2312F6C2-3456-4ADC-A26C-4BD2C5FAF368
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
23e9de587f95da891b2145e3fb13969052de1c82
P2860
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.